GLP-1 drugs are under fresh scrutiny over rare condition; here's what's happening
Studies, regulators and US litigation are looking at a possible link between GLP-1 drugs and a rare eye condition that can cause vision loss.
Attribution
This digest is published with acknowledgment to Business Today. For the complete analysis, headnotes, and citations, please refer to the source.
Read on Business Today
